Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Finding for Sugammadex and Neostigmine in Residual Neuromuscular Blockade
NCT00895609Phase 4Completed
- Sponsor
- Technical University of Munich
- Start
- Mar 2009
- Primary completion
- Aug 2009
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Technical University of Munich. Started Mar 2009; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT00895609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00895609.